Jacob Van Naarden, COO at Loxo Oncology, holds 29.20K shares in Eli Lilly & Co (Ticker: LLY), holds 0.00 shares in Loxo Oncology (Ticker: LOXO). Most recently, Jacob Van Naarden Bought ― shares of Eli Lilly & Co on Aug 13, 2025 for an estimated value of $647.36K.
What is the percentage of profitable transactions made by Jacob Van Naarden?
The percentage of profitable transactions made by Jacob Van Naarden is ―.
What is the average return per transaction made by Jacob Van Naarden?
The average return per transaction made by Jacob Van Naarden is ―.
What stocks does Jacob Van Naarden hold?
Jacob Van Naarden holds: LOXO, LLY stocks.
What was Jacob Van Naarden’s latest transaction?
Jacob Van Naarden latest transaction was an Informative Buy of $647.36K.
What was Jacob Van Naarden's most profitable transaction?
Jacob Van Naarden’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jacob Van Naarden's role in Loxo Oncology?
Jacob Van Naarden's role in Loxo Oncology is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.